Silverback Therapeutics Updates Strategic Priorities and Reports Fourth Quarter and Full Year 2021 Financial Results
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameARS Pharmaceuticals Inc (formerly Silverback Therapeutics Inc)
-
Registration countryUSA
-
IndustryPharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***









